Human NK Cell Cytoskeletal Dynamics and Cytotoxicity Are Regulated by LIM Kinase

• Published in: The Journal of immunology (1950) Vol. 205; no. 3; pp. 801 - 810
• Main Authors: Duvall, Melody G, Fuhlbrigge, Mary E, Reilly, Roisin B, Walker, Katherine H, Kılıç, Ayşe, Levy, Bruce D
• Format: Journal Article
• Language: English
• Published: United States 01.08.2020
• Subjects: Cytoskeleton - immunology; Dexamethasone - pharmacology; Humans; Killer Cells, Natural - immunology; Lim Kinases - immunology; Lipoxins - antagonists & inhibitors; Lipoxins - immunology
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.2000186

NK cells provide immune surveillance and host protection against viruses and tumors through their cytotoxic effector function. Cytoskeletal rearrangement is necessary for NK cell lytic granule trafficking and immune synapse formation to trigger apoptosis of targeted cells. LIM kinase (LIMK) regulates F-actin remodeling by phosphorylating cofilin to inhibit actin severing and depolymerization. In this study, in human NK cells, the glucocorticoid dexamethasone downregulated LIMK expression, F-actin accumulation at the immune synapse, lytic granule trafficking, and cytotoxicity. In contrast, the specialized proresolving mediator lipoxin A promoted NK cell LIMK expression, lytic granule polarization to the immune synapse and cytotoxicity. Using a LIMK inhibitor, we show that LIMK activity is necessary for NK cell cytotoxicity, including lipoxin A 's proresolving actions. Together, our findings identify LIMK as an important control mechanism for NK cell cytoskeletal rearrangement that is differentially regulated by glucocorticoids and specialized proresolving mediators to influence NK cell cytotoxicity.